Nitipol Srimongkolpithak

Statistics

Publications

Citations

245

H-Index

Active since

2014

Affiliations

National Science and Technology Development Agency(Current)

National Center for Genetic Engineering and Biotechnology

Imperial College London

Structural Genomics Consortium

University of Toronto

Nitipol Srimongkolpithak is an author at National Science and Technology Development Agency specializing in enzyme inhibition, medicinal chemistry, and pharmacology.

ORCID

Publications per year

2014–2023

Publications

Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells

Edward Curry, Ian Green, Nadine Chapman‐Rothe et al. · Clinical Epigenetics · 2015 · 81 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors

Nitipol Srimongkolpithak, Sandeep Sundriyal, Fengling Li et al. · MedChemComm · 2014 · 50 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Development of Diaminoquinazoline Histone Lysine Methyltransferase Inhibitors as Potent Blood‐Stage Antimalarial Compounds

Sandeep Sundriyal, Nicholas A. Malmquist, Joachim Caron et al. · ChemMedChem · 2014 · 39 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Semi-Synthesis of N-Aryl Amide Analogs of Piperine from Piper nigrum and Evaluation of Their Antitrypanosomal, Antimalarial, and Anti-SARS-CoV-2 Main Protease Activities

Rattanaporn Wansri, Aye Chan Khine Lin, Jutharat Pengon et al. · Molecules · 2022 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery of a Multifunctional Octapeptide from Lingzhi with Antioxidant and Tyrosinase Inhibitory Activity

Yodying Yingchutrakul, Sucheewin Krobthong, Kiattawee Choowongkomon et al. · Pharmaceuticals · 2022 · 19 citations · Full text

Life Sciences, Biochemistry, Enzymology +16

1–5 of 7